To be more accurate, the hyperactivation of the CXCL12/CXCR4/AKR3 axis is associated with increased tumor size, lower degree of cell differentiation, higher probability of recurrence, worse response to chemotherapy, and decreased overall survival [31,32]. The gene discussed is CXCR4; the disease is neoplasm.